Zeal Global Opportunities Fund has increased its stake in Ind-Swift Laboratories from 2.53% to 5.95% through preferential allotment by converting 24.68 lakh warrants into equity shares. Post-conversion, Ind-Swift’s equity capital rose to Rs. 67.21 Cr from Rs. 60.62 Cr. This boosted the fund's holding significantly, reflecting increased investor confidence and potential institutional interest in the company’s growth prospects.